Patents by Inventor Paul A. Belk

Paul A. Belk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070060965
    Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.
    Type: Application
    Filed: October 31, 2006
    Publication date: March 15, 2007
    Inventors: David Casavant, Paul Belk, Thomas Mullen, John Stroebel
  • Publication number: 20070060964
    Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.
    Type: Application
    Filed: October 31, 2006
    Publication date: March 15, 2007
    Inventors: David Casavant, Paul Belk, Thomas Mullen, John Stroebel
  • Publication number: 20070060963
    Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).
    Type: Application
    Filed: October 17, 2006
    Publication date: March 15, 2007
    Inventors: David Casavant, Paul Belk, Thomas Mullen, John Stroebel
  • Patent number: 7184831
    Abstract: A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes delivering a first therapy during a first delivery period, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate stored energy on the energy storage device. A determination is made as to whether to deliver the first therapy during a second delivery period subsequent to the first delivery period in response to the predetermined level of stored energy not being generated on the energy storage device. The device then delivers the first therapy during a third delivery period subsequent to the second delivery period in response to the first therapy not being delivered during the second delivery period and the predetermined level of stored energy not being generated on the energy storage device.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: February 27, 2007
    Assignee: Medtronic, Inc.
    Inventor: Paul A. Belk
  • Patent number: 7177683
    Abstract: A method and device for delivering anti-tachycardia pacing pulses that may be used to treat episodes of atrial or ventricular tachycardia. Episodes of atrial or ventricular tachycardia can occur while the heart is at a normal rhythm or an accelerated rhythm. The method and device is directed to determining an estimate of action potential duration of a heart that experiences episodes of atrial or ventricular tachycardia for use in determining a pacing interval for anti-tachycardia pacing pulses that may more effectively terminate the tachycardia.
    Type: Grant
    Filed: April 30, 2003
    Date of Patent: February 13, 2007
    Assignee: Medtronic, Inc.
    Inventor: Paul Belk
  • Patent number: 7174208
    Abstract: The present invention provides structures and methods for delivering a complex slow-rise defibrillation waveform wherein in lieu of the simple truncation of prior art defibrillation waveforms, when a predetermined amplitude is reached for an ascending waveform (e.g., a ramp waveform), the waveform transitions to an exponential decay portion for a period of time and at the expiration of the period of time, a truncation occurs. In the event that a first complex bi-phasic ramp wave form is implemented, a second opposite polarity waveform may be delivered. Said second waveform is preferably of similar shape to the first waveform, but of a less magnitude amplitude, although the second waveform may comprise a traditional waveform. The implementation and feasibility of the waveforms according to the present invention in an ICD or an AED is relatively simple while providing significant advantages not previously known or used in the prior art.
    Type: Grant
    Filed: October 24, 2003
    Date of Patent: February 6, 2007
    Assignee: Medtronic, Inc.
    Inventors: Paul J. DeGroot, Paul A. Belk
  • Publication number: 20070005113
    Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction however possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial based pacing).
    Type: Application
    Filed: June 29, 2006
    Publication date: January 4, 2007
    Inventors: David Casavant, Paul Belk, Thomas Mullen, John Stroebel
  • Patent number: 7151962
    Abstract: A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes a first circuit delivering a first therapy and a second circuit delivering a second therapy, the second circuit including an energy storage device for storing energy associated with the second therapy and a charging circuit selectively coupled to the storage device to generate the stored energy. A control circuit controls the first circuit and the second circuit to deliver the first therapy substantially simultaneous with the charging of the energy storage device in response to the predetermined event being detected, and decouples the energy storage device from the charging circuit during a redetect period subsequent to delivery of the first therapy. The control circuit recouples the energy storage device and the charging circuit in response to the microprocessor detecting the predetermined event during the redetect period.
    Type: Grant
    Filed: April 29, 2004
    Date of Patent: December 19, 2006
    Assignee: Medtronic, Inc.
    Inventor: Paul A. Belk
  • Patent number: 7130683
    Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial-based pacing).
    Type: Grant
    Filed: September 17, 2002
    Date of Patent: October 31, 2006
    Assignee: Medtronic, Inc.
    Inventors: David A. Casavant, Paul Belk, Thomas J. Mullen, John C. Stroebel
  • Publication number: 20060089677
    Abstract: Rate responsive pacing is limited in an atrial based pacing mode by the AV interval in order to avoid or minimize ventricular encroachment of atrial pacing. The AV or VA interval is used to permit rate responsiveness; modulate rate responsiveness or to determine a dynamic upper sensor rate.
    Type: Application
    Filed: October 25, 2004
    Publication date: April 27, 2006
    Inventors: David Casavant, Paul Belk
  • Publication number: 20050245979
    Abstract: A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes delivering a first therapy during a first delivery period, substantially simultaneous with coupling of a charging circuit and an energy storage device to generate stored energy on the energy storage device. A determination is made as to whether to deliver the first therapy during a second delivery period subsequent to the first delivery period in response to the predetermined level of stored energy not being generated on the energy storage device. The device then delivers the first therapy during a third delivery period subsequent to the second delivery period in response to the first therapy not being delivered during the second delivery period and the predetermined level of stored energy not being generated on the energy storage device.
    Type: Application
    Filed: April 29, 2004
    Publication date: November 3, 2005
    Inventor: Paul Belk
  • Publication number: 20050245980
    Abstract: A method and device for delivering a therapy in response to detection of abnormal cardiac rhythms that includes a first circuit delivering a first therapy and a second circuit delivering a second therapy, the second circuit including an energy storage device for storing energy associated with the second therapy and a charging circuit selectively coupled to the storage device to generate the stored energy. A control circuit controls the first circuit and the second circuit to deliver the first therapy substantially simultaneous with the charging of the energy storage device in response to the predetermined event being detected, and decouples the energy storage device from the charging circuit during a redetect period subsequent to delivery of the first therapy. The control circuit recouples the energy storage device and the charging circuit in response to the microprocessor detecting the predetermined event during the redetect period.
    Type: Application
    Filed: April 29, 2004
    Publication date: November 3, 2005
    Inventor: Paul Belk
  • Publication number: 20050137489
    Abstract: A method of predicting an arrhythmia, such as ventricular tachycardia, for example, in a medical device using a quantitative measure in order to allow assessment of patient risk and to enable preventative interventions by the device and clinicians. The trending of day and night average heart rates, along with patient physical activity can be analyzed to provide prediction of impending arrhythmia within weeks.
    Type: Application
    Filed: December 3, 2004
    Publication date: June 23, 2005
    Inventors: Troy Jackson, Paul Belk
  • Publication number: 20050055059
    Abstract: Pacing parameters are provided to address cross talk and intrinsic ventricular events occurring within a predefined blanking period following an atrial event. The parameters are used in conjunction with protocol for minimizing or reducing ventricular pacing, wherein ignoring intrinsic ventricular events during the blanking period might otherwise affect the performance of the protocol.
    Type: Application
    Filed: May 21, 2004
    Publication date: March 10, 2005
    Inventors: Robert Betzold, David Casavant, Paul Belk, Thomas Mullen, John Stroebel
  • Publication number: 20040220634
    Abstract: A method and device for delivering anti-tachycardia pacing pulses that may be used to treat episodes of atrial or ventricular tachycardia. Episodes of atrial or ventricular tachycardia can occur while the heart is at a normal rhythm or an accelerated rhythm. The method and device is directed to determining an estimate of action potential duration of a heart that experiences episodes of atrial or ventricular tachycardia for use in determining a pacing interval for anti-tachycardia pacing pulses that may more effectively terminate the tachycardia.
    Type: Application
    Filed: April 30, 2003
    Publication date: November 4, 2004
    Applicant: Medtronic, Inc.
    Inventor: Paul Belk
  • Patent number: 6772005
    Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: August 3, 2004
    Assignee: Medtronic, Inc.
    Inventors: David Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
  • Publication number: 20040143299
    Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.
    Type: Application
    Filed: January 12, 2004
    Publication date: July 22, 2004
    Applicant: Medtronic, Inc.
    Inventors: David Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel
  • Publication number: 20040116967
    Abstract: The present invention provides structures and methods for delivering a complex slow-rise defibrillation waveform wherein in lieu of the simple truncation of prior art defibrillation waveforms, when a predetermined amplitude is reached for an ascending waveform (e.g., a ramp waveform), the waveform transitions to an exponential decay portion for a period of time and at the expiration of the period of time, a truncation occurs. In the event that a first complex bi-phasic ramp wave form is implemented, a second opposite polarity waveform may be delivered. Said second waveform is preferably of similar shape to the first waveform, but of a less magnitude amplitude, although the second waveform may comprise a traditional waveform. The implementation and feasibility of the waveforms according to the present invention in an ICD or an AED is relatively simple while providing significant advantages not previously known or used in the prior art.
    Type: Application
    Filed: October 24, 2003
    Publication date: June 17, 2004
    Inventors: Paul J. DeGroot, Paul A. Belk
  • Publication number: 20030078627
    Abstract: A preferred atrial-based pacing method and apparatus is provided using an intelligent cardiac pacing system to having the ability to continue atrial-based pacing as long as relatively reliable AV conduction is present. In the event that such relatively reliable AV conduction is not present, mode switching to a DDD/R or a DDI/R pacing mode while continually biased to mode switch back to atrial-based pacing. The standard or relatively reliable AV conduction may be changed either automatically or manually. This increases pacing that utilizes natural AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting therefrom, while tolerating the occasional missed ventricular depolarization (i.e., non-conducted P-wave). In the event where relatively reliable AV conduction is not present, the pacing mode is switched to a DDD/R mode while detecting a return of the relatively reliable AV conduction (and resulting mode switch to preferred atrial-based pacing).
    Type: Application
    Filed: September 17, 2002
    Publication date: April 24, 2003
    Applicant: Medtronic, Inc.
    Inventors: David A. Casavant, Paul Belk, Thomas J. Mullen, John C. Stroebel
  • Publication number: 20020082646
    Abstract: An ADI/R mode is implemented using an intelligent pacing system to continually monitor ventricular response. This ensures AV conduction whenever possible so as to gain all the benefits of cardiac contractile properties resulting from native R-waves. In the event where AV conduction is blocked, the pacing mode is switched to a DDD/R mode to ensure a paced R-wave. Thereafter, subsequent to a completed interval of a p-wave, ADI/R pacing resumes to monitor ventricular response.
    Type: Application
    Filed: December 21, 2000
    Publication date: June 27, 2002
    Inventors: David Casavant, Paul A. Belk, Thomas J. Mullen, John C. Stroebel